If administered early, gene therapy has the potential to change the medical history of children born with metachromatic ...

Asked whether the episode was related to the complex partial seizure he suffered in February or whether the congressman had sought medical attention afterwards, Larson issued a statement Friday ...

In this placebo-bexicaserin switch population, a 57.3% reduction in countable motor seizures and 61.2% reduction in total seizures was observed, consistent with the response in non-naive ...

Lundbeck’s receptor superagonist designed to treat seizures associated with developmental and epileptic encephalopathies (DEEs) has seen a 61.2% reduction in total seizures in a Phase Ib/IIa trial.

The trial has seen the therapy able to elicit a 57.3% reduction in countable motor seizures and 61.2% reduction in total seizures. Credit: Shutterstock / Tunatura Lundbeck’s receptor superagonist ...

Okano said two patients recovered "some" motor function, with one subject regaining the ability to stand by using a support mechanism. The other two patients didn't experience any improvement in ...